As the terminal stage of various CVDs, HF is associated with a persistently high rate of morbidity, hospital readmission, and mortality in patients and has become a major public health problem worldwide, with more than 60 million cases diagnosed globally (90)
Quebecs public drug plan doesnt cover GLP-1s for obesity
Fortinos weight loss clinic
Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
This technology supports patients in making informed decisions about treatments such as Survodutide and Tirzepatide
While much of this market is driven by cancer and metabolic disease therapies, the off-label clinical use of peptides for mens health and anti-aging has gained momentum in urban centers like NYC, particularly among working professionals aged 3555 seeking edge-enhancement therapies